<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4A39B474-28F7-461F-B66C-39FD5C43BF4E"><gtr:id>4A39B474-28F7-461F-B66C-39FD5C43BF4E</gtr:id><gtr:name>State University of New York at Stony Brook</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7B1A15D2-38E4-47E5-9E56-B54D2168A3F3"><gtr:id>7B1A15D2-38E4-47E5-9E56-B54D2168A3F3</gtr:id><gtr:name>UCL Institute of Neurology</gtr:name><gtr:address><gtr:line1>Queen Square</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>Cancer Research</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A39B474-28F7-461F-B66C-39FD5C43BF4E"><gtr:id>4A39B474-28F7-461F-B66C-39FD5C43BF4E</gtr:id><gtr:name>State University of New York at Stony Brook</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7B1A15D2-38E4-47E5-9E56-B54D2168A3F3"><gtr:id>7B1A15D2-38E4-47E5-9E56-B54D2168A3F3</gtr:id><gtr:name>UCL Institute of Neurology</gtr:name><gtr:address><gtr:line1>Queen Square</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/AF64C6D0-EF9D-459C-BA4C-92D85A945E27"><gtr:id>AF64C6D0-EF9D-459C-BA4C-92D85A945E27</gtr:id><gtr:firstName>Albena</gtr:firstName><gtr:surname>Dinkova-Kostova</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C2764CF7-175F-445A-8347-C1416001F125"><gtr:id>C2764CF7-175F-445A-8347-C1416001F125</gtr:id><gtr:firstName>Geoffrey</gtr:firstName><gtr:surname>Wells</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FL01923X%2F1"><gtr:id>AB57E2B7-DDBE-4F68-A5B6-24F41CB74AE2</gtr:id><gtr:title>The Spatiotemporal Regulation of the Keap1/Nrf2 pathway</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L01923X/1</gtr:grantReference><gtr:abstractText>All living organisms have protective systems that allow their successful adaptation and survival under conditions of stress. One major way of protection is the Keap1/Nrf2 pathway. This pathway does not normally operate at its full potential, and can be activated by small molecules (inducers), some of which are present in vegetable-rich diets. Inducers react chemically with cysteine residues of the sensor protein Keap1, leading to stabilisation of transcription factor Nrf2, and consequently to increased expression of a network of genes with protective functions. Previous work has shown that activation of the Keap1/Nrf2 pathway is a very effective strategy for protection against chronic disease, but that in ageing model organisms, the ability to activate Nrf2 is progressively lost. Thus, there is a growing interest in the discovery and development of small-molecule modulators of Nrf2 activity to improve human health and delay ageing. 

We have recently developed a system which has allowed us to study the interactions between Nrf2 and Keap1 in single live cells, and discovered that Keap1 uses a unique cyclic mechanism to target Nrf2 for degradation. This project aims to employ our newly-established experimental system in order to: (i) determine the impact of the sensor cysteines of Keap1 which are most commonly modified by electrophiles on the Keap1: Nrf2 complex formation at basal state as well as following inducer treatment; (ii) identify potent non-electrophilic inducers which directly disrupt the protein: protein interaction between Keap1 and Nrf2, and evaluate the ability of such inducers to protect against oxidative stress, a critical contributor to the pathogenesis of essentially all chronic diseases and ageing; (iii) establish the effect on the interaction of Keap1 and Nrf2 of modulating the levels of p21 and p62, two critical protein regulators of the Nrf2 activity which are involved in two fundamental biological processes, apoptosis and autophagy, respectively. Together, these experiments will provide detailed understanding of the mechanisms controlling the interaction between Keap1 and Nrf2. This knowledge is essential for the design and implementation of new strategies aiming the modulation of Nrf2 activity for life-long health and wellbeing.</gtr:abstractText><gtr:technicalSummary>The transcription factor Nrf2 regulates the expression of more than 1% of the human genome, including detoxification, anti-inflammatory and antioxidant cytoprotective genes. Nrf2 dysregulation is causally-associated with the development of chronic diseases and ageing, and Nrf2 is considered a drug target for disease prevention and healthy ageing. Nrf2 is normally targeted for degradation by its major negative regulator, Keap1. In response to electrophiles and oxidants (termed inducers), which modify specific cysteines within Keap1, Nrf2 is stabilized, accumulates in the nucleus, and activates transcription of cytoprotective genes. Recently, using live cell imaging, we discovered that the Keap1 : Nrf2 interaction follows a cycle whereby the complex sequentially adopts two distinct conformations: &amp;quot;open&amp;quot;, in which Nrf2 interacts with one molecule of Keap1, followed by &amp;quot;closed&amp;quot;, in which Nrf2 binds to both members of the Keap1 dimer and allows Nrf2 ubiquitination. This project will test the hypothesis that the conformational cycling of the Keap1 : Nrf2 protein complex endows the Keap1/Nrf2-mediated cytoprotective response with regulatory flexibility with respect to both small molecule inducers as well as protein regulators. Specifically, we will determine the effect on the conformational cycling of the Keap1 : Nrf2 complex of: (i) the cysteines of Keap1 which are most commonly modified by electrophiles, (ii) non-electrophilic inducers which directly disrupt the interaction between Keap1 and Nrf2, and (iii) modulating the levels of p21 and p62, two critical protein regulators of Nrf2 activity. Together, these experiments will provide comprehensive understanding of the mechanisms controlling the interaction between Keap1 and Nrf2, leading to new strategies for targeting Nrf2 for life-long health and wellbeing.</gtr:technicalSummary><gtr:potentialImpactText>The proposed study will have an impact on both academic as well as pharmaceutical research and development. There are already indications that colleagues in industry would probably find aspects of this work of interest. For example, Amgen and AstraZeneca collaborate on an inflammation portfolio, in which Nrf2 activators are being evaluated as potential anti-inflammatory agents. Also, Biogen Idec, which is represented in the UK, has been working on an Nrf2-activating drug, dimethyl fumarate (BG-12), to treat multiple sclerosis. Presumably, Biogen Idec would also be interested in our findings as they will provide detailed insights into the molecular mechanism of action of compounds like BG-12. In addition, the development of new non-electrophilic Nrf2 activators (Aim 2) will be also of great interest to the pharmaceutical industry as they hold the promise of improved safety profile.

Importantly, because some inducers of the Keap1/Nrf2 pathway are present in edible plants, our research benefits scientists and health care professionals who are concerned with improved human nutrition, as well as plant geneticists who are interested in the development of edible plants with enhanced nutritional value. One prominent example is the BBSRC-funded work of Professor Richard Mithen at the John Innes Centre, Institute of Food Research, Norwich Research Park. Professor Mithen has developed the &amp;quot;Benefort&amp;eacute;&amp;quot; broccoli, a variety of broccoli with enhanced content of a compound called glucoraphanin, which upon ingestion, is converted to sulforaphane, a potent inducer of the Keap1/Nrf2 pathway. Numerous studies by many research groups, including ours, in various animal model systems have shown that sulforaphane has many health benefits, e.g. it can lower the risk for damage to the retina, heart disease, diabetes, cancer, and is thus considered to be a very promising dietary compound for healthy ageing. Indeed, broccoli or extracts of broccoli have been or currently are in 50 clinical trals for a number of indications, including cardiovascular disease, breast, bladder, lung, prostate and pancreatic cancer, asthma, obstructive lung disease, radiation dermatitis, and even autism (ClinicalTrials.gov).

In addition to academics and scientists, the project will be of interest to the general public. As an RC UK Academic Fellow, Albena Dinkova-Kostova has been involved in public outreach projects. One example is the &amp;quot;Light Up the Lab&amp;quot; project in which Albena presented her work to the 5th and 6th Form pupils in local secondary schools, at the schools themselves during their regular Higher classes, as well as during the course of science exhibitions at the Dundee Science Centre. Albena also has had groups of students spent time in her lab to receive hands-on-experience and appreciation for every day scientific research. All of these activities have been highly successful and have received a very positive feedback from the pupils and their biology teachers. The resources of the Revealing Research team at the University of Dundee to train the post-doctoral assistant in public contact activities are always available to us. As the proposed project progresses, the post-doctoral research assistant will receive training in public engagement and become involved in &amp;quot;Caf&amp;eacute; Science&amp;quot;, which provides a regular programme of discussion groups in local public venues such as coffee shops and bookshops. In addition, we will work with the Dundee Science Centre &amp;quot;Caf&amp;eacute; Sensation&amp;quot; to support their series of public lectures about ongoing research in Dundee, which are geared to young people and children. In terms of the wider community, the project will give the staff valuable training and experience in communicating their findings at both scientific and lay levels, which can only have positive benefits to society.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-09-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>333707</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>State University of New York (SUNY) at Stony Brook</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Stony Brook University</gtr:description><gtr:id>2229654B-FEBA-44D4-95ED-4E84C958BE39</gtr:id><gtr:impact>We have published a number of manuscripts on the chemistry and biological activity of new Inducers of transcription factor Nrf2 which are also anti-inflammatory agents.</gtr:impact><gtr:partnerContribution>Our collaborators have designed and synthesized the new chemical agents.</gtr:partnerContribution><gtr:piContribution>We have evaluated the biological activity of new chemical agents.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCL Institute of Neurology</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Molecular Neuroscience</gtr:department><gtr:description>UCL Institute of Neurology</gtr:description><gtr:id>D5644FE0-CDF6-4AC2-A034-13ECF07E31FC</gtr:id><gtr:impact>We have made new discoveries and published two manuscripts.</gtr:impact><gtr:partnerContribution>Our collaborators have provided their expertise in an area of biology (i.e. mitochondrial physiology) in which have not had prior experience.</gtr:partnerContribution><gtr:piContribution>We have provided the experimental systems to study the role of transcription factor Nrf2 in mitochondrial function.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine Johns Hopkins</gtr:department><gtr:description>Johns Hopkins University</gtr:description><gtr:id>BB48782A-4F43-4AE5-B614-944C25632687</gtr:id><gtr:impact>We have published several manuscripts describing the findings of our studies.</gtr:impact><gtr:partnerContribution>Our collaborators have performed the design and chemical synthesis, and have prepared the plant extracts for our human study.</gtr:partnerContribution><gtr:piContribution>We have evaluated the biological activity of new chemical agents, analogues of sulforaphane, and have conducted a double-blind placebo-controlled study in healthy human volunteers with sulforaphane-containing plant extracts.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL School of Pharmacy</gtr:department><gtr:description>UCL School of Pharmacy</gtr:description><gtr:id>B27564A5-DB98-4C4D-BB3C-416D0AEA76DA</gtr:id><gtr:impact>We have published a manuscript which includes data from our collaborative work.</gtr:impact><gtr:partnerContribution>Our collaborators have designed and synthesized new chemical agents.</gtr:partnerContribution><gtr:piContribution>We have tested new chemical agents developed by the collaborators in our biological systems.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>JWCC Open Day event</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>44DAEAE7-70B4-4964-8885-D9E067329D06</gtr:id><gtr:impact>This was an open day at our Cancer Centre with various public engagement activities. Our visitors found it very informative and enjoyable.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EwI</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5165B189-853C-4599-A50C-35C90266121E</gtr:id><gtr:impact>This activity is ongoing. Thus far it has informed the BBSRC on the breadth of public outreach activities of the University of Dundee.

Our case studies illustrate the versatility of activities aiming to benefit all members of our community.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biochemical Society Meeting (Cambridge)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5E7B56BC-9C26-489C-9F1C-1C8A5A0A710C</gtr:id><gtr:impact>an invited talk was given, which sparked questions and discussion afterwards.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>7th International Conference on Oxidative Stress in Skin Biology and Medicine, Andros, Greece</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C55F6001-5C16-4266-8424-B53F08D638BF</gtr:id><gtr:impact>I was invited to give a talk at the 7th International Conference on Oxidative Stress in Skin Biology and Medicine, Andros, Greece. many participants found the talk interesting, there were many questions and discussion. I was subsequently invited to give another by some of the people who were in attendance.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EastBio</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9D93FDE6-DA46-4A12-A74E-65F33F0B0826</gtr:id><gtr:impact>Gave a research presentation and was the theme leader for Training Strand 1 (Basic Bioscience Underpinning Health and Ageing) of the EastBio PhD programme.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Boehringer Ingelheim seminar (Vienna, Austria)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>38D581E7-52F4-4936-BC30-82BDA6F1A80C</gtr:id><gtr:impact>This was a seminar at the research division of Boehringer Ingelheim in Vienna, Austria. It was followed by discussions for a potential collaboration.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Goethe University seminar (Frankfurt, Germany)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C47D7C7B-F4EA-404C-AA75-71D50CC0E156</gtr:id><gtr:impact>This was an invited seminar at Goethe University.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>12th European Nutrition Conference (Berlin, Germany)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F9E10EC2-A50E-4710-A56E-00AD44920FB3</gtr:id><gtr:impact>The talk stimulated questions and discussion.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>In collaboration with researchers from Harvard Medical School, we have identified a new scaffold of Nrf2 activators with promise in Huntington's disease.</gtr:description><gtr:exploitationPathways>We are currently extending the initial findings into more detailed mechanistic studies and disease models, including cells from patients.</gtr:exploitationPathways><gtr:id>E4893BE0-94D1-4FC5-BFFB-1CD3CA25DEB3</gtr:id><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.massgeneral.org/about/pressrelease.aspx?id=1962</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/140A43F9-3F79-471E-BE2B-BC8F75153CA2"><gtr:id>140A43F9-3F79-471E-BE2B-BC8F75153CA2</gtr:id><gtr:title>Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function.</gtr:title><gtr:parentPublicationTitle>Biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/defa60eed89de2a7f74456bab1246412"><gtr:id>defa60eed89de2a7f74456bab1246412</gtr:id><gtr:otherNames>Esteras N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1431-6730</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FEC32167-4164-44D0-9A22-36DA25594BED"><gtr:id>FEC32167-4164-44D0-9A22-36DA25594BED</gtr:id><gtr:title>Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f1b002a684ee48c6cb838f5df325adc"><gtr:id>9f1b002a684ee48c6cb838f5df325adc</gtr:id><gtr:otherNames>Wells G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36479D90-BBE8-4AC3-AE1B-923E6CA183ED"><gtr:id>36479D90-BBE8-4AC3-AE1B-923E6CA183ED</gtr:id><gtr:title>Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e8f9b5d1c648dc0be4e0f5eab6700e9"><gtr:id>0e8f9b5d1c648dc0be4e0f5eab6700e9</gtr:id><gtr:otherNames>Bertrand HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2260D64E-5BEC-49D8-9B76-7DBCD29CA0E2"><gtr:id>2260D64E-5BEC-49D8-9B76-7DBCD29CA0E2</gtr:id><gtr:title>SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models.</gtr:title><gtr:parentPublicationTitle>Cell chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4728d71f037fa3be7608f26fd23f5bd"><gtr:id>c4728d71f037fa3be7608f26fd23f5bd</gtr:id><gtr:otherNames>Quinti L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4F828C17-9150-45DD-A33D-E645FCF58145"><gtr:id>4F828C17-9150-45DD-A33D-E645FCF58145</gtr:id><gtr:title>The spatiotemporal regulation of the Keap1-Nrf2 pathway and its importance in cellular bioenergetics.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6070dc679145e5833c4d0d09be8f3e26"><gtr:id>6070dc679145e5833c4d0d09be8f3e26</gtr:id><gtr:otherNames>Dinkova-Kostova AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40F24A0C-24AD-4FC4-9E92-FBEEBB5C643D"><gtr:id>40F24A0C-24AD-4FC4-9E92-FBEEBB5C643D</gtr:id><gtr:title>Regulation of the mammalian heat shock factor 1.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71be029abde16fb13633379ff0785349"><gtr:id>71be029abde16fb13633379ff0785349</gtr:id><gtr:otherNames>Dayalan Naidu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF80888E-47BE-421A-BB1B-DEFD7B9240AD"><gtr:id>EF80888E-47BE-421A-BB1B-DEFD7B9240AD</gtr:id><gtr:title>The emerging role of Nrf2 in mitochondrial function.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6070dc679145e5833c4d0d09be8f3e26"><gtr:id>6070dc679145e5833c4d0d09be8f3e26</gtr:id><gtr:otherNames>Dinkova-Kostova AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E5B93AB-70A3-434C-A185-578E5AD62ADE"><gtr:id>2E5B93AB-70A3-434C-A185-578E5AD62ADE</gtr:id><gtr:title>Transcription factors Hsf1 and Nrf2 engage in crosstalk for cytoprotection.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71be029abde16fb13633379ff0785349"><gtr:id>71be029abde16fb13633379ff0785349</gtr:id><gtr:otherNames>Dayalan Naidu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BD132F8-803F-4303-8002-1E509B270FF3"><gtr:id>3BD132F8-803F-4303-8002-1E509B270FF3</gtr:id><gtr:title>Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02b484cbe42c3ac68057ab287cac9129"><gtr:id>02b484cbe42c3ac68057ab287cac9129</gtr:id><gtr:otherNames>Tebay LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/74BC9D86-831B-4261-BB7C-7AD8C231735A"><gtr:id>74BC9D86-831B-4261-BB7C-7AD8C231735A</gtr:id><gtr:title>New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide Synthase.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L01923X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>1163A5D2-CE35-4C7E-904E-6FB2B5FA0C2A</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Multiprotein complexes</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>